Lauren Paulos, MPH, was a lecturer at the Archer Center, where she supervised Graduate Archer Fellows in the Health Policy Working Group. She is the legislative director for drugs in the Office of Legislation at the Food and Drug Administration (FDA). In this role, she directs and manages the FDA’s interactions with Congress related to human drugs and biological products. She served on the team that led the FDA’s response to the COVID-19 public health emergency and led the agency’s work with Congress to reauthorize the FDA’s user fee agreements in 2022. Prior to joining the FDA, she served in various capacities within Congress. She served in legislative roles for U.S. Representative Michael Burgess (TX-26) and former U.S. Representative John Culberson (TX-7). She also served as a health legislative assistant for former Senator Orrin Hatch from Utah, where she led his work on the FDA Reauthorization Act of 2017. Paulos holds a Bachelor of Science in environmental health from the University of Georgia and a Master of Public Health specializing in health policy from The George Washington University.